CLOs on the Move


 
Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Headquartered in Shanghai since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad and late-stage pipeline of innovative drug candidates. Based on our extensive track record of execution and delivering results, Zai Lab has earned the reputation as a trusted partner of choice for global biopharmaceutical companies seeking to not only access the Chinese market but ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Ann Beasley
Chief Compliance Officer Profile
F.Ty Edmondson
Chief Legal Officer Profile

Similar Companies

Numed Inc

Numed Inc is a Crossroads, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Florida Radiology Imaging

Florida Radiology Imaging is a Maitland, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Managed Health Network

Managed Health Network is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Bell Laboratories Inc.

Bell Laboratories Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Nuvectra

Nuvectra™ is a neuromodulation company committed to helping physicians improve the lives of people with chronic conditions through our medical devices. At Nuvectra, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson`s Disease. NeuroNexus, a subsidiary owned by Nuvectra, designs, manufactures, and markets leading-edge neural-interface technologies for the neuroscience clinical research market.